Brainsway Ltd. has made strategic investments in Neurolief and Axis to expand its influence in the neuromodulation market and enhance its offerings for treating mental health disorders.

Brainsway Ltd. is a pioneering company in non-invasive neuromodulation, specializing in treatments for major depressive disorder and obsessive-compulsive disorder, with a strong market presence and growth potential.